JANX

JANX R&D to Revenue

1258.96%Fiscal year

Period ending:

JANX FY R&D/Revenue%
JANX FY R&D/Revenue1410.04%-151.08%
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

JANX r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Janux Therapeutics Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
1,258.96%
645.901%
679.4754%
620.5411%
721.3913%
0%
0%

Compare r&d to revenue

All JANX financial metrics · JANX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.